Megan Baumgart
Impact in
-
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- PARP inhibition in cancer therapy
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 8
- Cancer survivorship and care 2
- HER2/EGFR in Cancer Research 2
- PARP inhibition in cancer therapy 2
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Mary W. Redman (2 shared papers)David R. Gandara (2 shared papers)Roy S. Herbst (3 shared papers)Scott Gettinger (2 shared papers)Karen Kelly (3 shared papers)Jean E. Patterson (1 shared paper)David J. Merkler (1 shared paper)Kathleen A. Merkler (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Blood Advances (2 papers)Clinical and Translational Science (1 paper)Annals of Oncology (1 paper)Translational Lung Cancer Research (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Megan Baumgart
17 papers receiving 161 citations
Peers
Comparison fields: 5 of 45
- Oncology 63
- Pulmonary and Respiratory Medicine 50
- Clinical Biochemistry 9
- Biochemistry 8
- Physiology 5
Countries citing papers authored by Megan Baumgart
This map shows the geographic impact of Megan Baumgart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Baumgart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Baumgart more than expected).
Fields of papers citing papers by Megan Baumgart
This network shows the impact of papers produced by Megan Baumgart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Baumgart. The network helps show where Megan Baumgart may publish in the future.
Co-authors
The 25 scholars most cited alongside Megan Baumgart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 53 | |
| 2 | 1999 | 49 | |
| 3 | 2015 | 13 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 8 | |
| 6 | 2020 | 7 | |
| 7 | 2021 | 6 | |
| 8 | 2023 | 4 | |
| 9 | 2024 | 2 | |
| 10 | 2021 | 2 | |
| 11 | 2019 | 2 | |
| 12 | 2020 | 2 | |
| 13 | 2016 | 2 | |
| 14 | 2020 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2026 | 0 |
About Megan Baumgart
Megan Baumgart is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Public Health, Environmental and Occupational Health and Genetics, having authored 18 papers that have together received 162 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Palliative Care and End-of-Life Issues (3 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Cancer survivorship and care (2 papers), Axon Guidance and Neuronal Signaling (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), HER2/EGFR in Cancer Research (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Oncology (63 citations), Pulmonary and Respiratory Medicine (50 citations), Clinical Biochemistry (9 citations), Biochemistry (8 citations) and Physiology (5 citations). Megan Baumgart has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Mary W. Redman, David R. Gandara, Roy S. Herbst, Scott Gettinger, Karen Kelly, Jean E. Patterson, David J. Merkler, Kathleen A. Merkler, Sarah B. Goldberg and Rogério Lilenbaum. Their work appears in journals such as Journal of Clinical Oncology, Blood Advances, Clinical and Translational Science, Annals of Oncology and Translational Lung Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.